GD2 or HER2 targeting T cell engaging bispecific antibodies to treat osteosarcomaJeong A Park, Nai‐Kong V. Cheung|Journal of Hematology & Oncology|2020Cited by 86
Interdomain spacing and spatial configuration drive the potency of IgG-[L]-scFv T cell bispecific antibodiesBrian H. Santich, Nai‐Kong V. Cheung, Hoa Tran et al.|Science Translational Medicine|2020Cited by 83
Potent ex vivo armed T cells using recombinant bispecific antibodies for adoptive immunotherapy with reduced cytokine releaseJeong A Park, Nai‐Kong V. Cheung|Journal for ImmunoTherapy of Cancer|2021Cited by 47